High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 162 participants.

Also called NCT05912686

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 162 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05912686
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05912686. Randomized; no masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
Condition
Mechanical Thrombectomy
Condition
Acute Ischemic Stroke
Intervention (Drug)
Atorvastatin 80mg
Intervention (Drug)
Atorvastatin 20mg
Lead sponsor
Zhongda Hospital (class: other)

Record details

Record id
cardio:ct-nct05912686
Content hash
a1a6b99a31d76469035b03a4d641983e94f8da38b9a40d4b6adc5a464ce9701d